Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
{ "products": [ { "_id": "66616410ccd5ce1a107590a0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RAPIGLINIDE VOG 1.0 ", "description": "RAPIGLINIDE VOG 1.0 \nRepaglinide (1mg), Voglibose (0.3mg)\nIntroduction to RAPIGLINIDE VOG 1.0\nRAPIGLINIDE VOG 1.0 is a combination medication that includes Repaglinide 1mg and Voglibose 0.3mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Repaglinide and Voglibose, RAPIGLINIDE VOG 1.0 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Repaglinide and Voglibose?\nOverview of Repaglinide\nRepaglinide is a meglitinide analog that helps control blood sugar levels by stimulating the pancreas to produce more insulin. It works by closing ATP-dependent potassium channels in the pancreatic beta-cell membrane, which leads to the opening of calcium channels and insulin release.\n\nOverview of Voglibose\nVoglibose is an alpha-glucosidase inhibitor that helps control blood sugar levels by slowing the digestion and absorption of carbohydrates in the small intestine. This leads to a slower and lower rise in blood glucose levels after meals.\n\nBenefits of RAPIGLINIDE VOG 1.0\nEffective Blood Sugar Management\nPostprandial Glucose Control: Repaglinide helps reduce blood sugar spikes after meals by stimulating rapid and short-acting insulin secretion. Voglibose complements this by slowing the absorption of carbohydrates, leading to a more gradual increase in blood glucose levels.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets both insulin secretion and carbohydrate absorption, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: RAPIGLINIDE VOG 1.0 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, RAPIGLINIDE VOG 1.0 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nHow to Use RAPIGLINIDE VOG 1.0\nDosage and Administration\nRecommended Dosage: The typical dosage of RAPIGLINIDE VOG 1.0 is one tablet taken before each main meal. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet before each meal to enhance its effectiveness in controlling postprandial blood sugar spikes. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take RAPIGLINIDE VOG 1.0 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/rapiglinide-vog-1-0-134237", "price": 189.0, "discountamount": 56.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Diet", "rapid", "Order", "EMAIL", "meals", "water", "slower", "action", "Support", "opening", "patients", "pancreas", "readings", "Benefits", "Overview", "Voglibose", "digestion", "main meal", "one tablet", "neuropathy", "full glass", "lower rise", "Guidelines", "information", "Adjustments", "Optimal Use", "Repaglinide", "retinopathy", "sterisonline", "sterispharma", "best results", "Introduction", "Reduced Risk", "CALL/WHATSAPP", "carbohydrates", "effectiveness", "typical dosage", "Consistent Use", "dual mechanism", "treatment plan", "Administration", "insulin release", "RAPIGLINIDE VOG", "small intestine", "two medications", "gradual increase", "calcium channels", "Exercise Adjunct", "excellent adjunct", "Recommended Dosage", "meglitinide analog", "Diabetes Management", "individual response", "healthcare provider", "blood sugar control", "blood glucose levels", "combination medication", "cardiovascular disease", "long-term complications", "lifestyle modifications", "carbohydrate absorption", "complementary mechanisms", "type 2 diabetes mellitus", "stable blood sugar levels", "alpha-glucosidase inhibitor", "Postprandial Glucose Control", "pancreatic beta-cell membrane", "short-acting insulin secretion", "comprehensive glycemic control", "postprandial blood sugar spikes", "ATP-dependent potassium channels", "Effective Blood Sugar Management", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1415, "imageuri": "https://productimages.withfloats.com/actual/666164117b1fc3f9dd4c947c.png", "tileimageuri": "https://productimages.withfloats.com/tile/666164117b1fc3f9dd4c947c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T07:24:00.417Z", "updatedon": "2026-03-13T07:22:38.341Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rapiglinide-vog-1-0-/1415", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RAPIGLINIDE VOG 1.0 ", "category": "DIABETIC RANGE", "tags": [ "RAPIGLINIDE VOG 1.0", "Repaglinide (1mg)", "Voglibose (0.3mg)", "Repaglinide 1 mg uses", "Repaglinide 1 mg price", "Repaglinide mechanism of action", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66616318d91d281c30c74f57", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RAPIGLINIDE VOG 0.5 ", "description": "RAPIGLINIDE VOG 0.5 \nRepaglinide (0.5mg), Voglibose (0.3mg)\nIntroduction to RAPIGLINIDE VOG 0.5\nRAPIGLINIDE VOG 0.5 is a combination medication that includes Repaglinide 0.5mg and Voglibose 0.3mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Repaglinide and Voglibose, RAPIGLINIDE VOG 0.5 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Repaglinide and Voglibose?\nOverview of Repaglinide\nRepaglinide is a meglitinide analog that helps control blood sugar levels by stimulating the pancreas to produce more insulin. It works by closing ATP-dependent potassium channels in the pancreatic beta-cell membrane, which leads to the opening of calcium channels and insulin release.\n\nOverview of Voglibose\nVoglibose is an alpha-glucosidase inhibitor that helps control blood sugar levels by slowing the digestion and absorption of carbohydrates in the small intestine. This leads to a slower and lower rise in blood glucose levels after meals.\n\nBenefits of RAPIGLINIDE VOG 0.5\nEffective Blood Sugar Management\nPostprandial Glucose Control: Repaglinide helps reduce blood sugar spikes after meals by stimulating rapid and short-acting insulin secretion. Voglibose complements this by slowing the absorption of carbohydrates, leading to a more gradual increase in blood glucose levels.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets both insulin secretion and carbohydrate absorption, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: RAPIGLINIDE VOG 0.5 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, RAPIGLINIDE VOG 0.5 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nHow to Use RAPIGLINIDE VOG 0.5\nDosage and Administration\nRecommended Dosage: The typical dosage of RAPIGLINIDE VOG 0.5 is one tablet taken before each main meal. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet before each meal to enhance its effectiveness in controlling postprandial blood sugar spikes. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take RAPIGLINIDE VOG 0.5 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/rapiglinide-vog-0-5-134238", "price": 145.0, "discountamount": 43.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Diet", "rapid", "Order", "EMAIL", "meals", "water", "slower", "action", "Support", "opening", "patients", "pancreas", "readings", "Benefits", "Overview", "Voglibose", "digestion", "main meal", "one tablet", "neuropathy", "full glass", "lower rise", "Guidelines", "information", "Adjustments", "Optimal Use", "Repaglinide", "retinopathy", "sterisonline", "sterispharma", "best results", "Introduction", "Reduced Risk", "CALL/WHATSAPP", "carbohydrates", "effectiveness", "typical dosage", "Consistent Use", "dual mechanism", "treatment plan", "Administration", "insulin release", "RAPIGLINIDE VOG", "small intestine", "two medications", "gradual increase", "calcium channels", "Exercise Adjunct", "excellent adjunct", "Recommended Dosage", "meglitinide analog", "Diabetes Management", "individual response", "healthcare provider", "blood sugar control", "blood glucose levels", "combination medication", "cardiovascular disease", "long-term complications", "lifestyle modifications", "carbohydrate absorption", "complementary mechanisms", "type 2 diabetes mellitus", "stable blood sugar levels", "alpha-glucosidase inhibitor", "Postprandial Glucose Control", "pancreatic beta-cell membrane", "short-acting insulin secretion", "comprehensive glycemic control", "postprandial blood sugar spikes", "ATP-dependent potassium channels", "Effective Blood Sugar Management", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1413, "imageuri": "https://productimages.withfloats.com/actual/6661631cc40ee9be019a5fd2.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661631cc40ee9be019a5fd2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T07:19:52.782Z", "updatedon": "2026-03-13T07:23:51.243Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//rapiglinide-vog-0-5-/1413", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RAPIGLINIDE VOG 0.5 ", "category": "DIABETIC RANGE", "tags": [ "RAPIGLINIDE VOG 0.5", "Repaglinide (0.5mg),", "Voglibose (0.3mg)", "voglibose 0.3mg price in india", "voglibose 0.3mg uses", "voglibose 0.3mg dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a952bdada41ea9aeeec5e4a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide injection 8 mg", "description": "The semaglutide injection, 8 mg, contains a total of 8 mg of semaglutide, a long-acting GLP-1 receptor agonist. It is used under medical supervision as part of treatment for appropriate adults with type 2 diabetes mellitus and, depending on the specific approved product and indication, for cardiovascular risk reduction and chronic weight management.\n1. Product Overview & Specifications\nAn 8 mg/3 mL semaglutide pen contains 8 mg of the active medicine in a 3 mL delivery system. When specifically designed to provide 2 mg per weekly dose, the total quantity can provide four 2 mg doses.\nActive Ingredient: Semaglutide\nTotal Strength: 8 mg\nExample Presentation: 8 mg/3 mL multi-dose pen\nDrug Class: GLP-1 receptor agonist\nRoute: Subcutaneous injection\nCommon Injection Areas: Abdomen, thigh, or upper arm\nAdministration: Once weekly, according to the prescribed schedule\nMechanism of Action\nSemaglutide mimics the activity of the naturally occurring hormone GLP-1 (glucagon-like peptide-1). It acts on GLP-1 receptors involved in blood-glucose regulation, digestion, and appetite.\nImproves glucose-dependent insulin release: Semaglutide encourages the pancreas to release insulin when blood glucose levels are elevated.\nReduces glucagon secretion: It lowers inappropriate glucagon release, helping reduce the amount of glucose produced by the liver.\nSlows gastric emptying: Semaglutide can delay the movement of food from the stomach, contributing to prolonged fullness.\nReduces appetite: Its effects on appetite-regulating pathways in the brain can decrease hunger and food intake.\n2. Primary Indications & Uses\nSemaglutide may be prescribed for several clinically established purposes depending on the specific formulation, approved labeling, and patient's medical condition.\nType 2 Diabetes Management\nSemaglutide can be used alongside appropriate diet and physical activity to improve blood-glucose control in adults with type 2 diabetes.\nCardiovascular Risk Reduction\nIn eligible adults with type 2 diabetes and established cardiovascular disease, certain semaglutide products have demonstrated a reduction in the risk of major cardiovascular events, including cardiovascular death, non-fatal heart attack, and non-fatal stroke.\nKidney Disease\nCertain semaglutide formulations and indications have demonstrated kidney-related benefits in specific populations. The appropriate product and indication should be determined by a healthcare professional.\nChronic Weight Management\nSemaglutide is also used for long-term weight management in eligible adults with obesity or overweight accompanied by weight-related health conditions, depending on the approved formulation and local prescribing guidance.\n3. Key Benefits of Semaglutide 8 mg Therapy\nClinical Area\nPotential Therapeutic Role\nBlood-Glucose Control\nHelps lower elevated blood glucose and improve glycemic control in appropriate patients.\nWeight Management\nReduces appetite and food intake, supporting sustained weight reduction when prescribed for this purpose.\nCardiovascular Health\nCertain approved semaglutide indications can reduce major cardiovascular event risk in eligible patients.\nMetabolic Support\nInfluences glucose regulation, appetite, insulin secretion, and glucagon activity.\nWeekly Administration\nA once-weekly injection can provide a convenient treatment schedule when prescribed.\n\n4. Side Effects & Safety Warnings\nCommon Adverse Reactions\nDigestive symptoms are among the most frequently reported adverse effects, particularly when treatment is initiated or the dose is increased.\nPossible side effects include:\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nBloating\nBelching\nIndigestion or heartburn\nReduced appetite\nThese effects may improve as the body becomes accustomed to treatment.\nFrequently Asked Questions\n1. How much weight can you lose with semaglutide?\nWeight reduction varies significantly between individuals and depends on the prescribed formulation, dose, treatment duration, diet, physical activity, and adherence. Clinical trials of approved weight-management regimens have demonstrated substantial average percentage weight loss over extended treatment periods.\n2. How much is 8 units of semaglutide in mL?\nOn a U-100 insulin syringe, 100 units corresponds to 1 mL, so 8 units corresponds to 0.08 mL. However, this conversion only describes syringe volume. It does not determine the amount of semaglutide in mg because the medication concentration varies between products. Always verify the exact concentration before measuring any dose.\n3. Is semaglutide injection safe for weight loss?\nSemaglutide can be an effective treatment for weight management when an approved formulation is prescribed to an eligible patient and used under appropriate medical supervision. It has important contraindications and warnings, including risks involving the gastrointestinal system, gallbladder, pancreas, kidneys, and thyroid C-cell tumors.\n4. How many mg of semaglutide are used for weight loss?\nThe appropriate dose depends on the specific semaglutide product. Weight-management treatment commonly begins with a lower dose and is gradually increased to a maintenance dose to improve tolerability. The maintenance dose should be determined according to the product's approved prescribing information and the healthcare professional's instructions.\n5. How much weight can I lose in 2 months with semaglutide?\nThere is no guaranteed amount of weight loss during the first two months. Individual results vary because treatment generally begins at a lower dose and is increased gradually. Diet, physical activity, starting weight, medical conditions, and adherence also affect the result.\n6. What happens when you stop semaglutide?\nAfter discontinuation, semaglutide gradually leaves the body. Appetite and food intake may increase as its effects decrease, and some people regain weight. Maintaining healthy eating and physical activity habits may help support weight management after treatment, but discontinuation should be discussed with a healthcare professional.\n7. How long does an 8 mg/3 mL semaglutide pen last?\nIf a specific 8 mg/3 mL pen is designed to deliver 2 mg per weekly dose, it contains four 2 mg doses and therefore provides approximately four weeks of treatment. The actual duration depends on the specific device and prescribed dosing instructions.\n8. What is semaglutide injection 8 mg used for?\nSemaglutide is used for approved indications such as improving blood-glucose control in type 2 diabetes and, depending on the formulation, supporting chronic weight management and reducing cardiovascular risk in eligible patients.\n9. What foods should be avoided while taking semaglutide?\nLarge, high-fat, greasy, or fried meals may worsen gastrointestinal symptoms such as nausea, bloating, and reflux. Smaller meals and balanced food choices may be easier to tolerate. Alcohol intake should also be discussed with a healthcare professional.\n10. Can you eat bananas while taking semaglutide?\nYes, bananas can generally be included in a balanced diet while using semaglutide. Portion size should be considered as part of an individual's overall calorie and carbohydrate intake, particularly for people managing diabetes.\n11. What is the best time of day to inject semaglutide?\nSemaglutide injections can generally be administered at any time of day, with or without meals, depending on the specific product instructions. The injection should be taken on the same day each week as prescribed.\n12. Will I lose weight during the first week of semaglutide?\nSome people may notice an early change in appetite or body weight, while others may not see a significant difference initially. Early treatment doses are generally introduced gradually to help the body adjust rather than to produce immediate maximum weight loss.\n13. How quickly does semaglutide start lowering blood sugar?\nSemaglutide begins acting after administration, but the degree and timing of blood-glucose improvement vary. Significant treatment effects develop progressively, particularly as the prescribed dose is gradually adjusted.\n14. What should I do if I miss a semaglutide dose?\nThe correct missed-dose procedure depends on the specific semaglutide product. Follow the instructions supplied with your prescribed product. Do not take an extra dose to compensate for a missed injection.\n15. Where is the best place to inject semaglutide?\nSemaglutide is administered subcutaneously. Common injection sites include the abdomen, front of the thigh, or upper arm, according to the product instructions. Rotating injection locations can help reduce repeated irritation at one site.\nConclusion\nSemaglutide injection 8 mg contains semaglutide, a long-acting GLP-1 receptor agonist that influences blood-glucose regulation, glucagon secretion, gastric emptying, and appetite. Depending on the specific formulation and approved indication, semaglutide may be used for type 2 diabetes management, chronic weight management, and cardiovascular risk reduction in eligible patients.\nAn 8 mg/3 mL presentation designed for 2 mg weekly dosing can provide four weekly doses. However, semaglutide concentrations, pen designs, approved doses, and indications can differ between products. Treatment should therefore follow the exact product instructions and a healthcare professional's prescription.", "price": 7800.0, "discountamount": 2340.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2498, "imageuri": "https://productimages.withfloats.com/actual/6a952bdd8359c1b7edbc7468.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a952bdd8359c1b7edbc7468.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-31T07:23:06.814Z", "updatedon": "2026-08-31T07:23:06.814Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-8-mg/2498", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 8MG", "category": "DIABETIC RANGE", "tags": [ "Semaglutide injection 8 mg", "semaglutide injection 8 mg", "semaglutide 8 mg injection uses", "semaglutide 8 mg injection benefits", "semaglutide 8 mg injection dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a43bee2d208c802be053f9d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg", "description": "Managing type 2 diabetes often requires more than a single medication to achieve long-term blood sugar control. Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg is a triple-combination prescription medicine formulated to help adults with type 2 diabetes maintain healthy glucose levels when diet, exercise, and single-drug therapy are not enough.\n\nThis advanced combination works through three different mechanisms to improve insulin sensitivity, reduce glucose production by the liver, and enhance the body's natural insulin response after meals. Because of its multi-action approach, it is frequently prescribed by healthcare professionals for patients requiring comprehensive glycemic control.\n\nIf you are searching for Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg, this guide covers everything you need to know—including how it works, benefits, dosage information, side effects, precautions, storage, and frequently asked questions.\n\nWhat is Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg?\n\nSitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg is a prescription oral anti-diabetic medicine used to manage Type 2 Diabetes Mellitus. It combines three clinically proven medicines into one convenient tablet to provide better blood sugar management throughout the day.\n\nThe formulation contains:\n\nSitagliptin 100 mg – A DPP-4 inhibitor that increases incretin hormones to improve insulin secretion.\nMetformin Hydrochloride 1000 mg Sustained Release – A biguanide that lowers glucose production by the liver and improves insulin sensitivity.\nPioglitazone 15 mg – A thiazolidinedione that enhances the body's response to insulin.\n\nTogether, these ingredients target multiple causes of high blood sugar, helping patients achieve better diabetes control while reducing the need for multiple separate medications.\n\nHow Does Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg Work?\n\nThis triple-combination tablet works through complementary mechanisms:\n\n1. Sitagliptin\n\nSitagliptin inhibits the DPP-4 enzyme, allowing incretin hormones to remain active longer. These hormones increase insulin release after meals and reduce excess glucagon production.\n\n2. Metformin SR\n\nMetformin Sustained Release decreases glucose production in the liver, reduces intestinal glucose absorption, and improves insulin sensitivity without causing excessive insulin release.\n\n3. Pioglitazone\n\nPioglitazone improves insulin sensitivity in muscle and fat tissues, enabling cells to utilize glucose more effectively.\n\nThe combination helps maintain consistent blood sugar levels throughout the day while lowering both fasting and post-meal glucose.\n\nWhy is This Triple Combination Important?\n\nType 2 diabetes progresses over time, making it difficult for many patients to control blood sugar using a single medication. A triple therapy offers several advantages:\n\nBetter HbA1c reduction\nMultiple mechanisms of action\nReduced insulin resistance\nImproved post-meal glucose control\nLower fasting blood sugar\nSimplified treatment with one tablet\nImproved medication adherence\nReduced need for additional medications\n\nHealthcare providers often prescribe this combination when dual therapy no longer provides adequate glucose control.\n\nKey Benefits of Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg\nExcellent Blood Sugar Control\n\nThe medicine helps reduce both fasting and postprandial blood glucose levels effectively.\n\nTriple Mechanism of Action\n\nEach ingredient targets a different pathway involved in diabetes, resulting in more comprehensive glycemic control.\n\nImproved Insulin Sensitivity\n\nPioglitazone increases insulin responsiveness, helping the body utilize glucose more efficiently.\n\nReduced Liver Glucose Production\n\nMetformin decreases glucose release from the liver, preventing unnecessary increases in blood sugar.\n\nSupports Long-Term Diabetes Management\n\nRegular use, alongside lifestyle modifications, contributes to improved HbA1c levels and reduced diabetes-related complications.\n\nConvenient Once-Daily Regimen\n\nCombining three medicines into a single tablet improves treatment convenience and supports better compliance.\n\nWho May Benefit from This Medicine?\n\nHealthcare professionals may prescribe this medication for adults with Type 2 Diabetes who:\n\nHave uncontrolled blood sugar despite dual therapy\nRequire triple oral anti-diabetic therapy\nHave elevated HbA1c levels\nNeed improved insulin sensitivity\nPrefer fewer tablets in their treatment plan\nAre following dietary and exercise recommendations but require additional glucose control\n\nThis medicine is not intended for Type 1 Diabetes or diabetic ketoacidosis.\n\nHow to Take Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg\n\nAlways follow your physician's instructions.\n\nGeneral recommendations include:\n\nTake once daily or as prescribed.\nSwallow the tablet whole.\nDo not crush, split, or chew the sustained-release tablet.\nTake with food to reduce stomach discomfort.\nTake it at the same time each day.\nContinue exercising and following a diabetic meal plan.\n\nNever stop treatment without consulting your healthcare provider.\n\nPossible Side Effects\n\nLike all prescription medicines, this combination may cause side effects, although not everyone experiences them.\n\nCommon side effects include:\n\nNausea\nStomach discomfort\nDiarrhea\nHeadache\nUpper respiratory infection\nWeight gain\nSwelling of feet or ankles\nMuscle aches\nDizziness\n\nSeek immediate medical attention if you experience:\n\nSevere allergic reaction\nPersistent vomiting\nDifficulty breathing\nSevere abdominal pain\nUnusual fatigue\nYellowing of skin or eyes\nSymptoms of lactic acidosis\nSigns of heart failure, such as rapid weight gain or shortness of breath\nPrecautions Before Using This Medicine\n\nInform your healthcare provider if you have:\n\nKidney disease\nLiver disease\nHeart failure\nBladder cancer history\nPancreatitis\nSevere dehydration\nAlcohol dependence\nVitamin B12 deficiency\nPlanned surgery or imaging with contrast dye\n\nWomen who are pregnant or breastfeeding should use this medicine only under medical supervision.\n\nDrug Interactions\n\nTell your doctor about all medicines you take, including:\n\nInsulin\nSulfonylureas\nDiuretics\nCorticosteroids\nThyroid medicines\nBlood pressure medicines\nRifampicin\nAlcohol\nCimetidine\nCertain antifungal medicines\n\nProper medication review helps minimize interaction risks.\n\nLifestyle Tips for Better Diabetes Control\n\nMedicine works best when combined with healthy lifestyle habits.\n\nRecommended practices include:\n\nFollow a balanced diabetic diet.\nExercise for at least 30 minutes most days.\nMonitor blood sugar regularly.\nMaintain a healthy body weight.\nStay hydrated.\nAvoid smoking.\nLimit alcohol intake.\nGet regular HbA1c tests.\nManage stress effectively.\nAttend routine medical check-ups.\nStorage Instructions\n\nStore the tablets:\n\nBelow 25°C\nIn a cool, dry place\nAway from moisture and direct sunlight\nIn the original packaging\nOut of reach of children and pets\n\nDo not use expired medicine.\n\nWhy Healthcare Professionals Choose This Triple Combination\n\nDoctors frequently recommend Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg because it addresses multiple aspects of diabetes management in a single formulation. By improving insulin secretion, reducing hepatic glucose production, and enhancing insulin sensitivity, it provides comprehensive glycemic control while simplifying treatment. When combined with a healthy lifestyle and regular medical follow-up, it can support long-term diabetes management and help reduce the risk of complications associated with uncontrolled blood sugar.\n\nConclusion\n\nSitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg is an effective prescription medication designed for adults with Type 2 Diabetes Mellitus who require stronger blood sugar management than single or dual therapy can provide. Its triple-action formula offers improved glycemic control, better insulin utilization, and convenient once-daily dosing. While highly effective, it should always be used under the guidance of a qualified healthcare professional, together with a balanced diet, regular physical activity, and routine blood sugar monitoring for the best long-term outcomes.\n\nHigh-Ranking FAQs (Google Search & Voice Search Optimized)\n1. What is Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg used for?\n\nIt is prescribed to help adults with Type 2 Diabetes Mellitus control blood sugar when lifestyle changes and other oral medicines do not provide adequate glycemic control.\n\n2. How does this triple-combination tablet work?\n\nIt combines three medicines that increase insulin release after meals, reduce glucose production by the liver, and improve the body's sensitivity to insulin, resulting in better overall blood sugar control.\n\n3. Can this medicine be taken once daily?\n\nYes. Many patients take it once daily, but the exact dosage and timing should always follow the prescribing doctor's instructions.\n\n4. Should I take this tablet with food?\n\nYes. Taking it with meals helps reduce stomach-related side effects associated with metformin and improves tolerability.\n\n5. Can this medicine cure diabetes?\n\nNo. It helps control blood sugar levels but does not cure Type 2 Diabetes. Long-term treatment, healthy eating, exercise, and regular monitoring remain essential.\n\n6. What should I do if I miss a dose?\n\nTake the missed dose as soon as you remember unless it is nearly time for your next scheduled dose. Do not take two doses together to make up for a missed dose.\n\n7. Can this medicine cause low blood sugar?\n\nOn its own, the risk is relatively low. However, the likelihood increases when it is used with insulin or sulfonylurea medicines, or if meals are skipped.\n\n8. Is this medicine safe for patients with kidney disease?\n\nPatients with kidney impairment require medical evaluation before using this medicine, particularly because metformin may not be suitable in severe kidney dysfunction.\n\n9. Can I drink alcohol while taking this medication?\n\nAlcohol intake should be limited or avoided, as excessive consumption may increase the risk of serious side effects, including lactic acidosis.\n\n10. Who should not use Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg?\n\nIt should not be used without medical advice by individuals with Type 1 Diabetes, diabetic ketoacidosis, severe kidney disease, certain liver conditions, or a history of serious hypersensitivity to any of its ingredients. Always consult your healthcare provider before starting treatment.", "price": 243.0, "discountamount": 73.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2462, "imageuri": "https://productimages.withfloats.com/actual/6a43bee3de301bd6de277db2.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a43bee3de301bd6de277db2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-06-30T13:04:34Z", "updatedon": "2026-06-30T13:04:34Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-100mg-metformin-hydrochloride-1000mg-sustained-release-pioglitazone-15-mg/2462", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN 3D 1000", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a1ec0fb574466f5ec21abe8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Benfotiamine,Mecobalamin,Pyridoxine Hydrochloride,Folic Acid,Inositol & Alpha Lipoic Acid Capsules", "description": "Generate unique content Seo geo friendly At least 1500 words humanizes and long and detailed articles on composition “ gliclazide and dapagliflozin combination\n\n” using brand name “ GLICLAGLAZE DAPA 60-10” use composition in heading “gliclazide and dapagliflozin combination ” and also use brand name Steris healthcare……. H1 How works……H2 Why its important …….H2 Key Benefits of ……….H3 What are the benefits …….H2 Side effects………H3 Serious Side Effects Of ……….H3 Available Substitute For ……….H2 Dosage Guidelines For …..H2 Precautions & Warnings: …..H2 with using and also Mechanism to action also with composition“gliclazide and dapagliflozin combination” Target Buyer intent INDICATIONS, EFFICACY AND CLINICAL EVIDENCE keywords”” : Conclusion: keep conclusion and Frequently Asked Questions 1 Is it safe to take gliclazide and dapagliflozin together? 2 What are the benefits of taking gliclazide and dapagliflozin concurrently? 3 Which pharmacies offer combined treatment options involving gliclazide and dapagliflozin? 4 Where can I find a doctor specializing in diabetes management who prescribes this combination? 5 Where can I buy gliclazide and dapagliflozin in one prescription? 6 Which pharmacies offer combined treatment options involving gliclazide and dapagliflozin?\n\nFor Further More Information: \n\nMail Us: contact@sterispharma.com or info@sterispharma.com\n\nCall Now: +918824175417, +919982524671\n\nBuy Now\n\nBelow is SEO-friendly, GEO-optimized, buyer-intent content for your product page targeting “gliclazide and dapagliflozin combination” and branded as GLICLAGLAZE DAPA 60-10 from Steris Healthcare.\n\nGliclazide and Dapagliflozin Combination – Complete Guide to GLICLAGLAZE DAPA 60-10 by Steris Healthcare\nGliclazide and Dapagliflozin Combination – Complete Guide to GLICLAGLAZE DAPA 60-10 by Steris Healthcare\n\nDiabetes mellitus is one of the most common chronic metabolic disorders affecting millions of people worldwide. Effective blood sugar management requires a comprehensive treatment approach that helps control glucose levels, reduce complications, and improve overall quality of life. The gliclazide and dapagliflozin combination has emerged as an effective therapeutic option for patients with Type 2 Diabetes Mellitus (T2DM) who require better glycemic control.\n\nGLICLAGLAZE DAPA 60-10, developed by Steris Healthcare, combines the proven efficacy of Gliclazide 60 mg Sustained Release and Dapagliflozin 10 mg to provide dual-action blood glucose control. This innovative combination works through complementary mechanisms to help diabetic patients achieve target blood sugar levels effectively.\n\nThis detailed guide covers the mechanism of action, indications, benefits, dosage guidelines, precautions, efficacy, clinical evidence, side effects, and frequently asked questions regarding the gliclazide and dapagliflozin combination.\n\nHow Gliclazide and Dapagliflozin Combination Works\n\nThe gliclazide and dapagliflozin combination utilizes two distinct yet complementary mechanisms to lower blood glucose levels.\n\nGliclazide Mechanism of Action\n\nGliclazide belongs to the sulfonylurea class of antidiabetic medications. It stimulates the pancreatic beta cells to release insulin, helping the body reduce elevated blood sugar levels.\n\nKey actions include:\n\nIncreases insulin secretion from the pancreas\nImproves glucose utilization\nReduces fasting blood glucose\nEnhances post-meal glucose control\nHelps maintain long-term glycemic stability\nDapagliflozin Mechanism of Action\n\nDapagliflozin belongs to the SGLT2 (Sodium-Glucose Cotransporter-2) inhibitor class.\n\nIt works by:\n\nBlocking glucose reabsorption in the kidneys\nIncreasing glucose excretion through urine\nReducing blood sugar independently of insulin\nPromoting mild weight reduction\nSupporting cardiovascular and renal protection\nCombined Mechanism of Action\n\nWhen combined, Gliclazide and Dapagliflozin provide:\n\nIncreased insulin secretion\nReduced renal glucose reabsorption\nBetter fasting and postprandial glucose control\nLower HbA1c levels\nImproved metabolic outcomes\n\nThis dual-action approach makes GLICLAGLAZE DAPA 60-10 a highly effective treatment for Type 2 Diabetes Mellitus.\n\nWhy Its Important\n\nManaging diabetes effectively is essential to prevent serious complications such as:\n\nHeart disease\nStroke\nKidney damage\nNerve damage\nVision loss\nDiabetic foot complications\n\nThe gliclazide and dapagliflozin combination is important because it addresses multiple aspects of blood sugar regulation while offering additional metabolic and cardiovascular benefits.\n\nFor patients whose diabetes remains uncontrolled with single-drug therapy, combination treatment provides enhanced glucose management and improved treatment outcomes.\n\nKey Benefits of Gliclazide and Dapagliflozin Combination\n\nGLICLAGLAZE DAPA 60-10 offers several significant benefits for diabetic patients.\n\nBetter Blood Sugar Control\n\nThe combination effectively lowers fasting and post-meal blood glucose levels.\n\nSignificant HbA1c Reduction\n\nClinical studies demonstrate meaningful reductions in HbA1c levels, helping patients achieve glycemic targets.\n\nWeight Management Support\n\nDapagliflozin promotes urinary glucose excretion, which may contribute to modest weight loss.\n\nReduced Risk of Diabetes Complications\n\nConsistent glycemic control lowers the risk of long-term diabetic complications.\n\nCardiovascular Benefits\n\nDapagliflozin has demonstrated cardiovascular protective effects in high-risk diabetic patients.\n\nRenal Protection\n\nThe medication supports kidney health and may slow progression of diabetic kidney disease.\n\nConvenient Once-Daily Dosing\n\nThe formulation enhances patient compliance through simple administration.\n\nWhat Are the Benefits of Gliclazide and Dapagliflozin Combination?\n\nPatients taking GLICLAGLAZE DAPA 60-10 may experience:\n\nImproved glycemic control\nBetter insulin utilization\nLower HbA1c values\nEnhanced metabolic function\nReduced fasting blood sugar\nBetter postprandial glucose management\nWeight management support\nImproved cardiovascular outcomes\nRenal protective effects\nIncreased treatment adherence\nIndications of Gliclazide and Dapagliflozin Combination\n\nGLICLAGLAZE DAPA 60-10 is indicated for:\n\nType 2 Diabetes Mellitus\n\nUsed in adults when diet, exercise, and monotherapy do not adequately control blood glucose.\n\nInadequate Glycemic Control\n\nRecommended for patients requiring intensified diabetes treatment.\n\nLong-Term Diabetes Management\n\nSupports sustained blood glucose control and prevention of complications.\n\nPatients with Cardiovascular Risk Factors\n\nMay provide additional cardiovascular benefits alongside glycemic management.\n\nEfficacy and Clinical Evidence\n\nSeveral clinical studies support the effectiveness of combining sulfonylureas such as Gliclazide with SGLT2 inhibitors like Dapagliflozin.\n\nHbA1c Reduction\n\nClinical trials demonstrate:\n\nSignificant reductions in HbA1c levels\nImproved fasting plasma glucose\nEnhanced postprandial glucose control\nWeight Reduction\n\nDapagliflozin contributes to calorie loss through urinary glucose excretion, leading to modest weight reduction.\n\nCardiovascular Outcomes\n\nResearch indicates that SGLT2 inhibitors may reduce hospitalization for heart failure and improve cardiovascular outcomes.\n\nRenal Outcomes\n\nStudies have shown benefits in slowing progression of diabetic kidney disease and improving renal function markers.\n\nThese findings make the gliclazide and dapagliflozin combination a valuable therapeutic option for comprehensive diabetes management.\n\nSide Effects of Gliclazide and Dapagliflozin Combination\n\nLike all medications, GLICLAGLAZE DAPA 60-10 may cause side effects.\n\nCommon side effects include:\n\nHeadache\nDizziness\nFrequent urination\nIncreased thirst\nNausea\nFatigue\nMild urinary tract infections\nGenital fungal infections\nLow blood sugar (hypoglycemia)\n\nMost side effects are mild and manageable.\n\nSerious Side Effects Of Gliclazide and Dapagliflozin Combination\n\nAlthough uncommon, serious side effects may include:\n\nSevere hypoglycemia\nDiabetic ketoacidosis\nSevere dehydration\nAcute kidney injury\nSerious urinary tract infections\nAllergic reactions\nSevere skin reactions\n\nSeek immediate medical attention if serious symptoms occur.\n\nAvailable Substitute For Gliclazide and Dapagliflozin Combination\n\nAlternative antidiabetic combinations may include:\n\nMetformin + Dapagliflozin\nSitagliptin + Dapagliflozin\nGliclazide + Metformin\nGlimepiride + Dapagliflozin\nEmpagliflozin-based combinations\n\nThe choice of therapy should always be determined by a healthcare professional based on individual patient needs.\n\nDosage Guidelines For Gliclazide and Dapagliflozin Combination\nRecommended Dose\n\nTake GLICLAGLAZE DAPA 60-10 exactly as prescribed by your physician.\n\nAdministration Instructions\nUsually taken once daily\nSwallow the tablet whole\nDo not crush or chew sustained-release tablets\nTake with or after food if advised\nMaintain adequate hydration\nMissed Dose\n\nIf a dose is missed:\n\nTake it as soon as remembered\nSkip if close to the next scheduled dose\nDo not double the dose\nOverdose\n\nSeek immediate medical attention in case of overdose.\n\nPrecautions & Warnings: Gliclazide and Dapagliflozin Combination\nMonitor Blood Sugar Regularly\n\nFrequent blood glucose monitoring helps optimize treatment outcomes.\n\nRisk of Hypoglycemia\n\nPatients should recognize symptoms such as:\n\nSweating\nTremors\nHunger\nConfusion\nDizziness\nMaintain Hydration\n\nDapagliflozin increases urinary glucose excretion and may increase fluid loss.\n\nKidney Function Monitoring\n\nRegular renal function assessments are recommended.\n\nLiver Function Monitoring\n\nPeriodic liver function evaluation may be necessary.\n\nPregnancy and Breastfeeding\n\nConsult a healthcare professional before use during pregnancy or lactation.\n\nAlcohol Consumption\n\nAlcohol may increase the risk of hypoglycemia and should be used cautiously.\n\nElderly Patients\n\nAdditional monitoring may be required due to increased sensitivity to treatment effects.\n\nWhy Choose GLICLAGLAZE DAPA 60-10 from Steris Healthcare?\n\nSteris Healthcare is committed to providing high-quality pharmaceutical products that support better patient outcomes.\n\nBenefits include:\n\nHigh manufacturing standards\nReliable quality assurance\nEffective diabetes management solution\nAdvanced combination therapy\nImproved patient compliance\nTrusted healthcare support\n\nGLICLAGLAZE DAPA 60-10 reflects Steris Healthcare’s dedication to innovation and excellence in diabetes care.\n\nConclusion\n\nThe gliclazide and dapagliflozin combination found in GLICLAGLAZE DAPA 60-10 offers a comprehensive and effective approach to Type 2 Diabetes Mellitus management. By combining the insulin-stimulating effects of Gliclazide with the glucose-excreting action of Dapagliflozin, this therapy provides superior blood sugar control, improved HbA1c reduction, cardiovascular support, renal protection, and enhanced patient convenience.\n\nFor patients seeking better glycemic control and long-term diabetes management, GLICLAGLAZE DAPA 60-10 from Steris Healthcare represents a scientifically supported and clinically effective treatment option.\n\nBuy Now\n\nFor product inquiries, bulk orders, franchise opportunities, and distribution partnerships:\n\nMail Us: contact@sterispharma.com or info@sterispharma.com\n\nCall Now: +91 8824175417, +91 9982524671\n\nBuy Now: Contact Steris Healthcare for product availability and ordering information.\n\nFrequently Asked Questions (FAQs)\n1. Is it safe to take gliclazide and dapagliflozin together?\n\nYes. Under medical supervision, the combination is considered safe and effective for managing Type 2 Diabetes Mellitus.\n\n2. What are the benefits of taking gliclazide and dapagliflozin concurrently?\n\nThe combination offers improved blood sugar control, HbA1c reduction, weight management support, cardiovascular benefits, and renal protection.\n\n3. Which pharmacies offer combined treatment options involving gliclazide and dapagliflozin?\n\nMany retail pharmacies, hospital pharmacies, and authorized pharmaceutical distributors stock gliclazide and dapagliflozin combination products. Availability may vary by location.\n\n4. Where can I find a doctor specializing in diabetes management who prescribes this combination?\n\nEndocrinologists, diabetologists, and experienced physicians commonly prescribe this combination for Type 2 Diabetes management.\n\n5. Where can I buy gliclazide and dapagliflozin in one prescription?\n\nYou can obtain the medication through a valid prescription from a registered healthcare professional and purchase it from authorized pharmacies.\n\n6. Which pharmacies offer combined treatment options involving gliclazide and dapagliflozin?\n\nLicensed pharmacies, diabetes specialty centers, and authorized pharmaceutical distributors often provide combination antidiabetic therapies, including GLICLAGLAZE DAPA 60-10.\n\ncreate 3d image without changing product image\nEdit\ncreate 3d image without changing product image please regenerate again\nEdit\nThis is my product page H1 Title “ Benfotiamine Mecobalamin,Pyridoxine Hydrochloride Folic Acid,Inositol & Alpha Lipoic Acid Capsules” generate complete as a buyer intent reading content on this targted keyword. content must between 1000- 1200 words \nBenfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules – Complete Guide for Nerve Health and Diabetic Neuropathy Support\n\nMaintaining healthy nerves is essential for overall well-being, especially for individuals living with diabetes, nutritional deficiencies, metabolic disorders, and nerve-related complications. Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules are scientifically formulated to provide comprehensive nutritional support for nerve health, improve nerve function, and help manage symptoms associated with diabetic neuropathy and peripheral nerve disorders.\n\nThis advanced combination contains essential neurotropic vitamins and antioxidants that work together to nourish damaged nerves, improve nerve conduction, reduce oxidative stress, and support overall neurological health. These capsules are widely prescribed by healthcare professionals for patients experiencing tingling, numbness, burning sensations, nerve pain, and vitamin B deficiencies.\n\nWhether you are searching for an effective solution for diabetic neuropathy or looking to support long-term nerve health, Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules offer a comprehensive approach to neurological wellness.\n\nWhat Are Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules?\n\nThese capsules combine six powerful ingredients known for their nerve-protective and restorative properties:\n\nBenfotiamine\nMecobalamin (Methylcobalamin)\nPyridoxine Hydrochloride (Vitamin B6)\nFolic Acid (Vitamin B9)\nInositol\nAlpha Lipoic Acid\n\nTogether, these ingredients help support healthy nerve function, improve metabolic processes, and protect nerve tissues from damage caused by oxidative stress and elevated blood sugar levels.\n\nHow Do Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules Work?\n\nThe effectiveness of this formulation lies in its multi-dimensional mechanism of action.\n\nBenfotiamine\n\nBenfotiamine is a fat-soluble derivative of Vitamin B1 that offers superior absorption.\n\nIt helps:\n\nProtect nerves from glucose-induced damage\nImprove nerve conductivity\nReduce diabetic complications\nSupport healthy metabolism\nMecobalamin\n\nMecobalamin is an active form of Vitamin B12 that plays a critical role in nerve regeneration.\n\nBenefits include:\n\nRepairing damaged nerve cells\nSupporting myelin sheath formation\nEnhancing nerve signal transmission\nReducing neuropathic symptoms\nPyridoxine Hydrochloride\n\nVitamin B6 supports neurological and metabolic functions.\n\nIt helps:\n\nMaintain healthy nerve cells\nImprove neurotransmitter production\nSupport brain and nervous system function\nFolic Acid\n\nFolic Acid contributes to:\n\nDNA synthesis\nRed blood cell production\nNerve cell development\nHomocysteine reduction\nInositol\n\nInositol assists in:\n\nNerve signaling pathways\nCellular communication\nMetabolic regulation\nNeurological function support\nAlpha Lipoic Acid\n\nAlpha Lipoic Acid is a potent antioxidant.\n\nIt helps:\n\nNeutralize free radicals\nReduce oxidative stress\nImprove nerve blood flow\nRelieve symptoms of diabetic neuropathy\nKey Benefits of Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules\n\nThis unique formulation offers multiple health benefits.\n\nSupports Nerve Regeneration\n\nThe combination promotes repair and regeneration of damaged nerve tissues.\n\nHelps Manage Diabetic Neuropathy\n\nMany diabetic patients experience:\n\nTingling sensations\nBurning feet\nNumbness\nSharp nerve pain\n\nThese capsules help manage such symptoms effectively.\n\nReduces Oxidative Stress\n\nAlpha Lipoic Acid protects nerves from oxidative damage caused by free radicals.\n\nImproves Nerve Conduction\n\nMecobalamin and Benfotiamine help restore healthy nerve signaling pathways.\n\nEnhances Energy Metabolism\n\nB-complex vitamins improve cellular energy production and metabolic efficiency.\n\nSupports Brain and Cognitive Function\n\nEssential vitamins support neurological health and mental performance.\n\nHelps Prevent Vitamin Deficiencies\n\nProvides important nutrients often deficient in diabetic and elderly patients.\n\nWhy Doctors Recommend Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules\n\nHealthcare professionals commonly prescribe this combination because it addresses the underlying nutritional and oxidative factors contributing to nerve damage.\n\nDoctors often recommend these capsules for:\n\nDiabetic neuropathy\nPeripheral neuropathy\nVitamin B12 deficiency\nNerve pain management\nNutritional supplementation\nNeurological disorders\nRecovery from nerve injuries\n\nThe synergistic action of these ingredients offers broader therapeutic benefits than single-nutrient supplements.\n\nIndications\n\nBenfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules are commonly indicated for:\n\nDiabetic Neuropathy\n\nHelps reduce symptoms associated with diabetes-related nerve damage.\n\nPeripheral Neuropathy\n\nSupports nerve health in patients experiencing nerve dysfunction.\n\nVitamin B Complex Deficiencies\n\nProvides nutritional support for individuals with inadequate vitamin intake.\n\nNerve Pain\n\nHelps manage neuropathic discomfort and sensory disturbances.\n\nMetabolic Neuropathy\n\nSupports patients affected by metabolic conditions impacting nerve function.\n\nNeurological Support\n\nUseful in maintaining healthy nervous system function.\n\nWho Should Consider These Capsules?\n\nThese capsules may benefit:\n\nIndividuals with diabetes\nPatients experiencing numbness or tingling\nElderly individuals with nerve weakness\nPeople recovering from neurological disorders\nIndividuals with vitamin B deficiencies\nPatients with chronic nerve pain\n\nA healthcare professional can determine if this supplement is appropriate based on individual medical needs.\n\nDosage and Administration\n\nAlways take Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules as directed by your healthcare provider.\n\nGeneral Guidelines\nUsually taken once daily or as prescribed\nSwallow the capsule whole with water\nPreferably taken after meals\nFollow the recommended dosage schedule\n\nDo not exceed the prescribed dose without medical advice.\n\nPossible Side Effects\n\nMost patients tolerate these capsules well. However, some individuals may experience mild side effects.\n\nCommon side effects may include:\n\nNausea\nStomach discomfort\nMild headache\nDizziness\nBloating\nSkin rash\nAllergic reactions\n\nThese side effects are generally temporary and manageable.\n\nPrecautions and Warnings\n\nBefore taking these capsules, consider the following precautions:\n\nConsult Your Doctor If You Have:\nKidney disease\nLiver disorders\nSevere diabetes complications\nAllergies to any ingredient\nPregnancy and Breastfeeding\n\nUse only under medical supervision during pregnancy and lactation.\n\nDrug Interactions\n\nInform your doctor about:\n\nAntidiabetic medications\nAnticonvulsants\nVitamin supplements\nPrescription medications\nRegular Monitoring\n\nPatients with diabetes should continue monitoring blood glucose levels as advised.\n\nWhy Choose This Advanced Nerve Health Formula?\n\nThe combination of Benfotiamine, Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol, and Alpha Lipoic Acid provides comprehensive support through multiple mechanisms.\n\nKey advantages include:\n\nMulti-nutrient nerve support\nEnhanced antioxidant protection\nImproved nerve regeneration\nBetter diabetic neuropathy management\nConvenient single-capsule formulation\nLong-term neurological health benefits\n\nThis makes it an excellent choice for individuals seeking a scientifically formulated nerve support supplement.\n\nConclusion\n\nBenfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules represent a comprehensive solution for supporting nerve health, managing diabetic neuropathy, and addressing nutritional deficiencies that affect neurological function. The synergistic combination of neurotropic vitamins and powerful antioxidants helps repair damaged nerves, improve nerve conduction, reduce oxidative stress, and promote overall neurological wellness.\n\nFor individuals experiencing nerve pain, numbness, tingling sensations, or diabetic neuropathy symptoms, these capsules offer an effective and clinically trusted option. When used under medical supervision, they can play a valuable role in maintaining healthy nerve function and improving quality of life.\n\nFrequently Asked Questions (FAQs)\n1. What are Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules used for?\n\nThey are primarily used to support nerve health, manage diabetic neuropathy, and treat vitamin B deficiencies.\n\n2. Can these capsules help with diabetic neuropathy?\n\nYes. The combination is commonly prescribed to help reduce symptoms such as tingling, numbness, burning sensations, and nerve pain associated with diabetic neuropathy.\n\n3. How long does it take to see results?\n\nResults vary depending on the severity of nerve damage and individual health conditions. Consistent use as prescribed is important.\n\n4. Are these capsules safe for long-term use?\n\nWhen taken under medical supervision, they are generally considered safe for long-term nutritional and neurological support.\n\n5. Can non-diabetic patients take these capsules?\n\nYes. They may also be prescribed for vitamin deficiencies, peripheral neuropathy, and other nerve-related conditions.\n\n6. Do these capsules require a prescription?\n\nAvailability may vary by region, but it is always recommended to use them under the guidance of a healthcare professional.", "price": 390.0, "discountamount": 117.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2435, "imageuri": "https://productimages.withfloats.com/actual/6a1ec0fefe6140386d7a9074.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a1ec0fefe6140386d7a9074.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-06-02T11:39:39.761Z", "updatedon": "2026-06-04T07:08:32.501Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//benfotiamine-mecobalamin-pyridoxine-hydrochloride-folic-acid-inositol-alpha-lipoic-acid-capsules/2435", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NUTRIDIAB PN", "category": "NEUROLOGY RANGE", "tags": [ "Benfotiamine,Mecobalamin,Pyridoxine Hydrochloride,Folic Acid,Inositol & Alpha Lipoic Acid Capsules", "Methylcobalamin alpha lipoic acid Pyridoxine Folic Acid Benfotiamine", "Benfotiamine Mecobalamin Pyridoxine Hydrochloride Folic Acid Inositol Alpha Lipoic Acid Capsules", "Buy Benfotiamine Mecobalamin Alpha Lipoic Acid Capsules Online", "Buy Benfotiamine Mecobalamin Alpha Lipoic Acid Capsules Online", "Diabetic Neuropathy Treatment Capsules", "Benfotiamine and Mecobalamin Capsules for Nerve Pain", "Alpha Lipoic Acid Capsules for Diabetic Neuropathy", "Vitamin B Complex and Alpha Lipoic Acid Capsules", "Benfotiamine Mecobalamin Capsules Product Image", "Best Capsules for Diabetic Nerve Damage", "Nerve Regeneration and Nerve Support Capsules", "Vitamin B12 and Alpha Lipoic Acid Capsules", "Nerve Strengthening Capsules with Benfotiamine", "Benfotiamine Mecobalamin Alpha Lipoic Acid Capsules for Neuropathy" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6961f2c52800555f6696ac8f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin Phosphate 100 mg", "description": "GLISITAPTIN 100 is a pharmaceutical formulation containing Sitagliptin Phosphate 100 mg as its active ingredient. This medication represents a significant advancement in the management of type 2 diabetes mellitus, offering patients an effective oral treatment option that works through an innovative mechanism of action. As part of the DPP-4 inhibitor class of antidiabetic medications, GLISITAPTIN 100 has emerged as a trusted choice for healthcare providers and patients seeking reliable glycemic control with a favorable safety profile.\nThe brand name GLISITAPTIN 100 signifies quality, efficacy, and a commitment to helping individuals with type 2 diabetes achieve better health outcomes. Each tablet is precisely formulated to deliver the optimal therapeutic dose of sitagliptin phosphate, ensuring consistent and predictable results in blood sugar management.\nUnderstanding Sitagliptin Phosphate\nSitagliptin phosphate is a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor that has revolutionized diabetes treatment since its introduction. Unlike older diabetes medications that work through insulin secretion or glucose absorption mechanisms alone, sitagliptin operates through the incretin system—a natural bodily process that regulates blood glucose levels in response to food intake.\nThe 100 mg strength available in GLISITAPTIN 100 represents the standard therapeutic dose for most adult patients, providing optimal efficacy while maintaining an excellent safety margin. This once-daily formulation simplifies treatment regimens and promotes better adherence, which is crucial for long-term diabetes management success.\nHow GLISITAPTIN 100 Works\nGLISITAPTIN 100 works through a sophisticated yet elegant mechanism that harnesses your body's natural glucose regulation system. When you eat, your intestines release hormones called incretins, specifically GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). These incretins have multiple beneficial effects: they stimulate insulin secretion from the pancreas, suppress glucagon release (which reduces glucose production by the liver), and slow gastric emptying.\nHowever, these beneficial incretins are rapidly broken down by an enzyme called DPP-4, limiting their glucose-lowering effects. GLISITAPTIN 100 inhibits this DPP-4 enzyme, allowing incretins to remain active in your bloodstream for longer periods. This results in better insulin secretion when blood glucose is elevated, reduced glucagon levels, and ultimately improved blood sugar control throughout the day.\nImportantly, because this mechanism is glucose-dependent, GLISITAPTIN 100 primarily works when blood sugar is elevated, which significantly reduces the risk of hypoglycemia (dangerously low blood sugar) compared to some other diabetes medications.\nPrimary Uses and Indications\nType 2 Diabetes Mellitus Management: GLISITAPTIN 100 is primarily indicated for improving glycemic control in adult patients with type 2 diabetes mellitus. It can be prescribed as:\n\nMonotherapy: As a first-line treatment for patients who cannot achieve adequate control through diet and exercise alone, particularly when metformin is contraindicated or not tolerated\nCombination Therapy: Alongside metformin, sulfonylureas, thiazolidinediones, or insulin when these medications alone do not provide sufficient glucose control\nTriple Therapy: In combination with two other antidiabetic agents when dual therapy fails to achieve target HbA1c levels\n\nThe medication is particularly suitable for patients who require effective glucose control but have concerns about weight gain or hypoglycemia, as GLISITAPTIN 100 is weight-neutral and has a low hypoglycemia risk when used as monotherapy.\nKey Benefits of GLISITAPTIN 100\n1. Effective Glycemic Control\nClinical studies have demonstrated that GLISITAPTIN 100 significantly reduces HbA1c levels (a measure of long-term blood sugar control) by approximately 0.5-1.0%, helping patients achieve and maintain target glucose levels. This improvement translates to reduced risk of diabetes-related complications over time.\n2. Low Hypoglycemia Risk\nUnlike sulfonylureas or insulin, GLISITAPTIN 100 has a glucose-dependent mechanism, meaning it primarily works when blood sugar is elevated. This dramatically reduces the risk of hypoglycemic episodes, providing patients with greater safety and peace of mind, especially important for elderly patients or those with unpredictable meal schedules.\n3. Weight Neutral\nGLISITAPTIN 100 does not cause weight gain, a significant advantage over some other diabetes medications like insulin, sulfonylureas, or thiazolidinediones. Maintaining a healthy body weight is crucial for overall diabetes management and cardiovascular health.\n4. Once-Daily Convenience\nThe single daily dose requirement of GLISITAPTIN 100 simplifies treatment regimens, making it easier for patients to maintain adherence. Better adherence directly correlates with improved glycemic control and better long-term outcomes.\n5. Pancreatic Preservation\nBy working through the incretin system, GLISITAPTIN 100 may help preserve pancreatic beta-cell function, potentially slowing the progression of type 2 diabetes. This represents a significant long-term benefit beyond simple glucose control.\n6. Cardiovascular Safety\nClinical trials have demonstrated cardiovascular safety with sitagliptin, an important consideration given that cardiovascular disease is the leading cause of morbidity and mortality in patients with type 2 diabetes.\n7. Renal Dosing Available\nWhile the 100 mg dose is standard, sitagliptin can be adjusted for patients with kidney impairment, making it accessible to a broader patient population, including those with diabetic nephropathy.\n8. Well-Tolerated\nGLISITAPTIN 100 generally has a favorable side effect profile, with most patients experiencing minimal adverse effects, contributing to better quality of life during treatment.\nDosage and Administration\nThe standard recommended dose of GLISITAPTIN 100 is one tablet taken orally once daily, with or without food. The medication can be taken at any time of day, though taking it at the same time daily helps establish a routine and ensures consistent blood levels.\nFor patients with moderate to severe kidney disease, dosage adjustments may be necessary. Your healthcare provider will determine the appropriate dose based on your kidney function tests. It's crucial to follow your doctor's instructions precisely and not adjust your dose without medical guidance.\nPotential Side Effects\nWhile GLISITAPTIN 100 is generally well-tolerated, like all medications, it may cause side effects in some individuals:\nCommon Side Effects (Affecting 1-10% of patients):\n\nUpper respiratory tract infections\nNasopharyngitis (common cold symptoms)\nHeadache\nNausea\nAbdominal pain\nDiarrhea\n\nThese side effects are typically mild and often resolve on their own as your body adjusts to the medication.\nLess Common but Serious Side Effects:\n\nPancreatitis: Severe abdominal pain that may radiate to the back, with or without vomiting, requires immediate medical attention\nSevere Joint Pain: Persistent, severe joint pain has been reported in some patients; inform your doctor if this occurs\nAllergic Reactions: Rare cases of serious allergic reactions including anaphylaxis, angioedema, and severe skin reactions have occurred\nHeart Failure: In patients with existing heart disease, worsening heart failure has been reported\nBullous Pemphigoid: A rare skin condition requiring discontinuation of the medication\n\nWhen Used with Other Diabetes Medications:\nWhen GLISITAPTIN 100 is combined with sulfonylureas or insulin, the risk of hypoglycemia increases. Your doctor may reduce the dose of these medications when adding GLISITAPTIN 100 to your regimen.\nPrecautions and Contraindications\nDo Not Use GLISITAPTIN 100 if:\n\nYou are allergic to sitagliptin or any ingredients in the formulation\nYou have type 1 diabetes or diabetic ketoacidosis\nYou are under 18 years of age (safety and efficacy not established)\n\nUse with Caution if:\n\nYou have a history of pancreatitis\nYou have kidney disease (dose adjustment required)\nYou have heart failure\nYou are pregnant or planning to become pregnant\nYou are breastfeeding\n\nImportant Patient Information\nMonitoring: Regular monitoring of blood glucose levels and HbA1c testing (typically every 3-6 months) is essential to assess treatment effectiveness and make necessary adjustments.\nLifestyle Factors: GLISITAPTIN 100 works best when combined with a healthy diet, regular physical activity, and weight management. Medication alone cannot substitute for comprehensive lifestyle management.\nMissed Dose: If you miss a dose, take it as soon as you remember on the same day. If it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Never double up doses.\nStorage: Store GLISITAPTIN 100 at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children.\nDrug Interactions\nGLISITAPTIN 100 has few significant drug interactions, contributing to its safety profile. However, inform your healthcare provider about all medications, supplements, and herbal products you're taking. Particular attention should be paid to:\n\nOther diabetes medications (may require dose adjustments)\nDigoxin (levels may be slightly increased)\nMedications affecting kidney function\n\nConclusion\nGLISITAPTIN 100 (Sitagliptin Phosphate 100 mg) represents a modern, effective, and well-tolerated option for managing type 2 diabetes mellitus. Its innovative mechanism through the incretin system offers multiple advantages including effective glucose control, low hypoglycemia risk, weight neutrality, and once-daily convenience. These benefits make it an excellent choice for many patients, whether used alone or in combination with other antidiabetic medications.", "price": 464.0, "discountamount": 139.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2272, "imageuri": "https://productimages.withfloats.com/actual/6961f2c8ba33389b8e9f0122.png", "tileimageuri": "https://productimages.withfloats.com/tile/6961f2c8ba33389b8e9f0122.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-10T06:33:41.727Z", "updatedon": "2026-03-13T05:59:37.431Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-phosphate-100-mg/2272", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLISITAPTIN 100", "category": "DIABETIC RANGE", "tags": [ "sitagliptin phosphate 100 mg tablet uses", "sitagliptin phosphate 100 mg dosage", "sitagliptin phosphate 100 mg side effects", "sitagliptin phosphate 100 mg benefits", "sitagliptin phosphate 100 mg price in india", "sitagliptin phosphate tablets 100 mg", "what is sitagliptin phosphate 100 mg used for", "how sitagliptin phosphate works in diabetes", "sitagliptin phosphate 100 mg for type 2 diabetes", "sitagliptin phosphate 100 mg mechanism of action", "sitagliptin phosphate tablet how to take", "medicine to control blood sugar sitagliptin", "tablet for post meal blood sugar control", "sitagliptin phosphate for high blood sugar", "can sitagliptin phosphate cause weight gain" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6911af10f122e2a45d230b07", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg & Glimepirde 2 mg", "description": "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 2 mg is a triple-combination oral anti-diabetic medication formulated to achieve optimal blood sugar control in adults with Type 2 Diabetes Mellitus (T2DM). This unique blend brings together three complementary agents — Sitagliptin (a DPP-4 inhibitor), Metformin (a biguanide), and Glimepiride (a sulfonylurea) — that work through distinct mechanisms to enhance glucose regulation, improve insulin sensitivity, and support overall metabolic balance.\n\nThis advanced combination therapy is prescribed when monotherapy or dual therapy fails to achieve adequate glycemic control. It helps reduce both fasting plasma glucose (FPG) and postprandial glucose (PPG) levels, promoting stable long-term glycemic management.\n\nUses of Sitagliptin + Metformin + Glimepiride\n\nThis fixed-dose combination is primarily indicated for the management of Type 2 Diabetes Mellitus in adults. It is especially beneficial for patients whose blood sugar levels remain uncontrolled despite treatment with Metformin and Glimepiride or Metformin and Sitagliptin alone.\n\nIts main objectives include:\n\nControlling elevated blood glucose levels in adults with Type 2 diabetes\n\nReducing the risk of diabetes-related complications such as neuropathy, nephropathy, and cardiovascular diseases\n\nSupporting better insulin utilization by the body\n\nComplementing diet, exercise, and lifestyle modification to maintain optimal glycemic balance\n\nMechanism of Action\n\nEach component of this combination plays a vital role in maintaining blood sugar control:\n\nSitagliptin (50 mg) – A Dipeptidyl Peptidase-4 (DPP-4) inhibitor that enhances the activity of incretin hormones. These hormones stimulate insulin release and suppress glucagon production when blood glucose levels rise, thereby improving post-meal glucose control.\n\nMetformin Hydrochloride (1000 mg) – A biguanide that lowers glucose production in the liver and increases the body’s sensitivity to insulin. It also decreases intestinal glucose absorption, making it an essential first-line therapy in diabetes management.\n\nGlimepiride (2 mg) – A sulfonylurea that stimulates pancreatic beta cells to release more insulin, especially when blood glucose levels are high. It works synergistically with Metformin and Sitagliptin for more effective glycemic control.\n\nKey Benefits\n\nTriple Mechanism for Superior Control:\nBy combining three potent agents, the medication addresses multiple pathways of glucose regulation—insulin secretion, insulin sensitivity, and hepatic glucose output—resulting in comprehensive and consistent control of blood sugar levels.\n\nEffective Glycemic Stability:\nThe combination helps maintain target HbA1c levels and reduces both fasting and post-meal glucose spikes without significant weight gain when used with proper diet and exercise.\n\nReduced Risk of Diabetic Complications:\nLong-term blood sugar control minimizes the risk of complications such as kidney disease, vision problems, nerve damage, and heart conditions associated with uncontrolled diabetes.\n\nConvenient Fixed-Dose Formulation:\nCombining three medications into a single tablet simplifies dosing schedules, improves patient adherence, and reduces pill burden, which is crucial for long-term treatment success.\n\nImproved Insulin Efficiency:\nEnhances the body's natural insulin response and glucose metabolism, allowing for smoother daily energy levels and reduced fatigue associated with hyperglycemia.\n\nPossible Side Effects\n\nWhile this combination is generally well tolerated, some patients may experience side effects, especially at the beginning of therapy. Common and rare side effects include:\n\nHypoglycemia (low blood sugar): More likely when meals are skipped or during excessive physical exertion. Symptoms include sweating, dizziness, and rapid heartbeat.\n\nGastrointestinal disturbances: Such as nausea, vomiting, diarrhea, abdominal discomfort, or loss of appetite (mostly due to Metformin).\n\nHeadache or Weakness: Usually mild and transient.\n\nAllergic reactions: Rarely, rash or itching may occur.\n\nLactic Acidosis (rare but serious): A potential complication of Metformin, particularly in patients with kidney impairment or excessive alcohol consumption.\n\nWeight gain: Mild weight gain may occur due to Glimepiride’s insulin-enhancing effect.\n\nPrecautions:\n\nRegular monitoring of blood sugar levels and kidney function is essential.\n\nAvoid alcohol and consult a doctor before using this medicine if you have liver or kidney disease.\n\nThe medication should not be used in patients with Type 1 diabetes or diabetic ketoacidosis.\n\nConclusion\n\nThe combination of Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 2 mg represents a powerful and balanced therapy for adults with Type 2 Diabetes Mellitus, especially those requiring triple-drug intervention to achieve desired glycemic control. Its multi-targeted approach ensures effective management of both fasting and postprandial glucose levels, thereby improving long-term metabolic health and reducing the risk of complications.", "price": 295.0, "discountamount": 89.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2197, "imageuri": "https://productimages.withfloats.com/actual/6911af137e4c90e1dc453884.png", "tileimageuri": "https://productimages.withfloats.com/tile/6911af137e4c90e1dc453884.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-10T09:23:28.795Z", "updatedon": "2026-03-13T10:41:32.995Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-50-mg-metformin-hydrochloride-1000-mg-glimepirde-2-mg/2197", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM 50+1000+2 ", "category": "DIABETIC RANGE", "tags": [ "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 2 mg", "anti-diabetic medication", "blood sugar control", "Type 2 Diabetes Mellitus" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "glimepiride voglibose metformin", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/69abe998ad5b8f3f9ba863c2.png", "tileimageuri": "https://productimages.withfloats.com/tile/69abe998ad5b8f3f9ba863c2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2026-03-13T10:35:41.824Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glimepiride-voglibose-metformin/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "DIABETIC RANGE", "tags": [ "glimepiride voglibose metformin tablets", "glimepiride voglibose metformin combination", "glimepiride voglibose metformin dosage", "glimepiride voglibose metformin uses", "glimepiride voglibose metformin composition", "glimepiride voglibose metformin tablets ip", "glimepiride voglibose metformin triple combination", "glimepiride voglibose metformin for type 2 diabetes", "triple drug combination for type 2 diabetes", "diabetes medicine for high fasting and pp sugar", "medicine for uncontrolled diabetes type 2", "combination tablets for diabetes management", "combination tablets for diabetes management", "when to take glimepiride voglibose metformin tablets", "who should take glimepiride voglibose metformin", "benefits of glimepiride voglibose metformin tablets", "side effects of glimepiride voglibose metformin" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "68b0256b813270ffac595cb0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "trelagliptin 100 mg", "description": "TRELAQWK 100 is an advanced oral antidiabetic medication containing Trelagliptin 100 mg, specifically designed for adults with type 2 diabetes mellitus (T2DM). Belonging to the class of Dipeptidyl Peptidase-4 (DPP-4) inhibitors, this formulation helps improve blood glucose control when used along with a proper diet and regular exercise.\nWith its once-weekly dosage regimen, TRELAQWK 100 offers a convenient treatment option, enhancing patient compliance and simplifying long-term diabetes management.\nKey Ingredient\nTrelagliptin 100 mg\nA long-acting DPP-4 inhibitor that regulates blood glucose levels by enhancing incretin hormones. These incretins stimulate insulin secretion and suppress glucagon release, helping to achieve better glycemic control.\nKey Benefits of TRELAQWK 100\nWeekly dosing ensures greater convenience and adherence\nReduces both fasting and postprandial blood sugar levels\nSupports natural blood sugar regulation without weight gain\nLow risk of hypoglycemia, especially when used as monotherapy or with non-insulin therapies\nCan be prescribed as monotherapy or in combination with other antidiabetic agents like metformin or sulfonylureas\nHow TRELAQWK 100 Works\nTRELAQWK 100 functions by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).\nThese incretin hormones:\nStimulate insulin secretion in response to meals\nReduce glucagon release, lowering blood sugar levels\nThanks to its extended half-life, trelagliptin allows for once-weekly dosing, unlike other DPP-4 inhibitors that require daily administration.\nDirections for Use\nDosage: Take one tablet of TRELAQWK 100 once weekly, or as directed by your physician\nAdministration: May be taken with or without food, ideally on the same day each week\nMissed dose: Do not double the dose; consult your healthcare provider for guidance\nPossible Side Effects\nTRELAQWK 100 is usually well-tolerated, but some individuals may experience:\nMild headache\nNasopharyngitis (common cold-like symptoms)\nConstipation\nUpper respiratory tract infections\nRare skin allergies (rash, itching)\n👉 If you experience persistent abdominal pain, severe rashes, or symptoms suggestive of pancreatitis, stop the medication and seek medical care immediately.", "price": 517.0, "discountamount": 156.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2166, "imageuri": "https://productimages.withfloats.com/actual/68b0256ebb42c3d551ad314c.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b0256ebb42c3d551ad314c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T09:46:19.602Z", "updatedon": "2026-03-13T10:23:49.272Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//trelagliptin-100-mg/2166", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRELAQWK 100", "category": "DIABETIC RANGE", "tags": [ "trelagliptin 100 mg", "diabetes mellitus (T2DM)", "blood sugar levels", "Reduces both fasting and postprandial blood sugar levels.", "Nasopharyngitis." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }

Still searching for
rapid acting insulin secretion medication?

Still searching for
rapid acting insulin secretion medication?

Chat with us